SCHEMBL2472950

SCHEMBL2472950

NC(=O)C1(C(Cc2ccccc2)C2=COCO2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.36
ALPI P09923 1/20 0.36
PKM P14618 1/20 0.36
PTGS1 P23219 1/20 0.36
XIAP P98170 1/20 0.36
SLC7A5 Q01650 1/20 0.36
CYP1A2 P05177 1/20 0.34
SRR Q9GZT4 2/20 0.33
SLC1A3 P43003 2/20 0.33
SLC1A2 P43004 2/20 0.33
SLC1A1 P43005 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP2D6 P10635 1/20 0.33
HDAC8 Q9BY41 2/20 0.32
POLB P06746 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SLC15A1 P46059 1/20 0.32
MDM2 Q00987 1/20 0.32
TSHR P16473 1/20 0.32
ANPEP P15144 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3563505 0.77 MIF (0.43) EPHX1ALPIPKMPTGS1XIAP
SCHEMBL2466830 0.77 EPHX1 (0.55) EPHX1ALPIPKMPTGS1XIAP
SCHEMBL3607845 0.75 SLC1A3 (0.49) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL1462830 0.74 CYP1A2 (0.44) EPHX1ALPIPKMPTGS1XIAP
SCHEMBL4888830 0.73 EPHX1 (0.38) EPHX1ALPIPKMPTGS1XIAP
SCHEMBL4619739 0.73 SLC1A3 (0.43) EPHX1ALPIPKMPTGS1XIAP
SCHEMBL5073587 0.73 MIF (0.39) EPHX1ALPIPKMPTGS1XIAP
SCHEMBL506238 0.73 LMNA (0.37) EPHX1ALPIPKMPTGS1XIAP
SCHEMBL5806034 0.71 EPHX1 (0.41) EPHX1ALPIPKMPTGS1XIAP
SCHEMBL1430902 0.71 MIF (0.56) ALPIPKMPTGS1XIAPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501830-B1 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES ACTELION PHARMACEUTICALS LTD (CH) 2011-10-05 EP claimed